[Expert recommendations for the prevention and control of pediatric respiratory syncytial virus infections in China (2023 edition)].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Zhonghua yi xue za zhi [Zhonghua Yi Xue Za Zhi] 2023 Oct 31; Vol. 103 (40), pp. 3155-3159.
  • Publication Type:
    English Abstract; Journal Article
  • Language:
    Chinese
  • Additional Information
    • Corporate Authors:
      Subspecialty Group of Respiratory Diseases, the Society of Pediatrics, Chinese Medical Association; Child Health Special Committee, Chongqing Maternal and Child Health Association; Vaccine and Health Branch of China Health Culture Association
    • Source:
      Publisher: Zhonghua yi xue hui Country of Publication: China NLM ID: 7511141 Publication Model: Print Cited Medium: Print ISSN: 0376-2491 (Print) Linking ISSN: 03762491 NLM ISO Abbreviation: Zhonghua Yi Xue Za Zhi Subsets: MEDLINE
    • Publication Information:
      Publication: Beijing : Zhonghua yi xue hui
      Original Publication: Beijing : Zhonghua yi xue hui.
    • Subject Terms:
      Respiratory Syncytial Virus Infections*/epidemiology ; Respiratory Syncytial Virus Infections*/prevention & control ; Respiratory Syncytial Virus, Human* ; Respiratory Tract Infections*/prevention & control; Child, Preschool ; Humans ; Infant ; Antibodies, Monoclonal ; China/epidemiology
    • Abstract:
      Respiratory syncytial virus (RSV) is one of the major pathogens responsible for acute lower respiratory tract infections (LRTI) and hospitalizations in children. It is also the primary viral pathogen causing lower respiratory tract infections in children under 5 years old, posing a significant threat to child health. In order to advance RSV prevention and control efforts and comprehensively explore RSV disease burden, epidemiological patterns, development and regulation of preventive and therapeutic measures, as well as the formulation of related strategies for prevention and control, the Editorial Board of the Chinese Medical Association Chinese Medical Journal convened the "Chinese Respiratory Syncytial Virus Forum" in December 2022. Participating experts, focusing on the current research status and developmental requirements concerning respiratory syncytial virus, engaged in discussions and exchanges, culminating in the formulation of expert recommendations for the prevention and control of pediatric respiratory syncytial virus infections in China: (1) Strengthen research on RSV epidemiological characteristics and disease burden; (2) Establish a collaborative, multi-departmental, and multi-disciplinary approach for sustained, multicenter, long-term monitoring; (3) Emphasize innovation, research, development, and implementation of vaccines, monoclonal antibodies, and diagnostic methods; (4) Propel the formulation and implementation of RSV immunoprophylaxis strategies; (5) Coordinate and allocate pediatric medical and health resources rationally to prevent nosocomial infections.
    • Contributed Indexing:
      Local Abstract: [Publisher, Chinese] 呼吸道合胞病毒（RSV）是造成儿童急性下呼吸道感染发病和住院的主要病原体之一，也是目前导致5岁以下儿童罹患下呼吸道感染（LRTI）的首要病毒性病原，严重危害儿童健康。为进一步推进RSV防控工作，全面探讨RSV疾病负担、流行规律变迁、防治手段研发与监管及防控相关策略的制定等，中华医学会中华医学杂志编委会于2022年12月召开了“中华RSV论坛”。与会专家围绕RSV研究现状及发展需求，交流探讨后形成了我国儿童RSV感染防控专家倡议：（1）加强对RSV流行特征及疾病负担研究；（2）联合多部门多领域，开展多中心长期持续性监测；（3）重视疫苗、单克隆抗体及检测方法的创新、研发与引入工作；（4）推动RSV免疫预防策略的制定与实施；（5）统筹协调合理分配儿科医疗卫生资源，防止院内感染。.
    • Accession Number:
      0 (Antibodies, Monoclonal)
    • Publication Date:
      Date Created: 20231025 Date Completed: 20231030 Latest Revision: 20231030
    • Publication Date:
      20231031
    • Accession Number:
      10.3760/cma.j.cn112137-20230712-01213
    • Accession Number:
      37879868